Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

New England Journal of Medicine

Volumn 343, Issue 26 I, 2000, Pages 1917-1924

  Whitney, Cynthia G ^a,j   Farley, Monica M ^b   Hadler, James ^c   Harrison, Lee H ^d   Lexau, Catherine ^e   Reingold, Arthur ^f   Lefkowitz, Lewis ^g   Cieslak, Paul R ^h   Cetron, Martin ^a   Zell, Elizabeth R ^a   Jorgensen, James H ⁱ   Schuchat, Anne ^a   Facklam, Richard R ^a   Bennett, Nancy M ^k  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CDC   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MINNESOTA DEPARTMENT OF HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h OREGON DEPARTMENT OF HUMAN SERVICES   (United States)

ⁱ UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^j CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^k Monroe County Department of Public Health   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; COTRIMOXAZOLE; ERYTHROMYCIN; MEROPENEM; PENICILLIN DERIVATIVE; STREPTOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL INFECTION; CHILD; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PREVALENCE; PRIORITY JOURNAL; RACE; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; PREVALENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 0034727809     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200012283432603     Document Type: Article

References (40)

1. Bacterial meningitis in the United States in 1995
2. The problem of resistant bacteria for the management of acute otitis media
3. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media
4. Incidence of community-acquired pneumonia requiring hospitalization: Results of a population-based active surveillance study in Ohio
5. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia
6. Pneumococcal bacteremia - No change in mortality in 30 years: Analysis of 104 cases and review of the literature
7. Emergence of drug-resistant pneumococcal infections in the United States
8. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis
9. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae
10. Otitis media complications and treatment failures: Implications of pneumococcal resistance
11. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain
12. Bacteriologic response to oral cephalosporins: Are established susceptibility breakpoints appropriate in the case of acute otitis media?
13. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae
14. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children
15. Failure of pneumonia treatment associated with highly resistant pneumococci in a child
16. Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia
17. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
18. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence
19. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
20. Acute otitis media: Management and surveillance in an era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
21. Community-acquired pneumonia in adults: Guidelines for management
22. Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
23. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae
24. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
25. Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season
26. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98
27. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
28. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci
29. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta
30. Antibiotic use in urban whites and blacks: The Minnesota Heart Survey
31. Trends in antimicrobial drug prescribing among office-based physicians in the United States
32. Geocoding and linking data from population-based surveillance and the US Census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections
33. Geographic variation in penicillin resistance in Streptococcus pneumoniae - Selected sites, United States, 1997
34. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
35. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid
36. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
37. In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: Correlation with penicillin resistance